Mix Sector Stocks News: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Box, Inc. (NYSE:BOX), Caesars Entertainment Corporation (NASDAQ:CZR), DR Horton Inc. (NYSE:DHI), Whitestone REIT (NYSE:WSR)

On Jan. 26, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer and Mr. Stephen Tulipano, Chief Financial Officer of Aldeyra, will participate in the Canaccord Genuity Rare Disease, BioPharma One-on-One Day, being held on Tuesday, February 3, 2015 in New York, NY. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) belongs to Healthcare sector. Its weekly performance is -3.05%. On last … Continue reading Mix Sector Stocks News: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Box, Inc. (NYSE:BOX), Caesars Entertainment Corporation (NASDAQ:CZR), DR Horton Inc. (NYSE:DHI), Whitestone REIT (NYSE:WSR)

Kevin Long01/2701/27

Why Need to Watch : QUALCOMM (NASDAQ:QCOM), Facebook Inc (NASDAQ:FB), Devon Energy Corporation (NYSE:DVN), Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Navios Maritime Acquisition (NYSE:NNA)

QUALCOMM, Inc. (NASDAQ:QCOM) announced that its subsidiary, Qualcomm Technologies, Inc., has taken a further step towards the vision of demonstrating how technology innovations can help address some of the challenges the education sector faces, by completing the acquisition of EmpoweredU, a pioneer in the development of an intuitive, mobile-centric cloud-based learning environment that is both device and operating system agnostic. The integration of EmpoweredU, with … Continue reading Why Need to Watch : QUALCOMM (NASDAQ:QCOM), Facebook Inc (NASDAQ:FB), Devon Energy Corporation (NYSE:DVN), Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Navios Maritime Acquisition (NYSE:NNA)

John Meady07/31

Biotech Unusual Volume: Aldeyra Therapeutics (NASDAQ:ALDX), Alcobra (NASDAQ:ADHD), Receptos (NASDAQ:RCPT), Celsus Therapeutics (NASDAQ:CLTX)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) rallied to a new all-time high Thursday after Aegis Capital began coverage of the biotech company working to develop treatments for rare skin and eye diseases with a Buy rating. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was 12.26% in last session and finished the day at $7.51. Traded volume was 134,905.00million shares in the last session and the average volume of … Continue reading Biotech Unusual Volume: Aldeyra Therapeutics (NASDAQ:ALDX), Alcobra (NASDAQ:ADHD), Receptos (NASDAQ:RCPT), Celsus Therapeutics (NASDAQ:CLTX)

John Meady06/20

Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) quiet period is set to expire on Wednesday, June 11th. Aldeyra Therapeutics had issued 1,500,000 shares in its IPO on May 2nd, AR Network reports. The total size of the offering was $12,000,000 based on an initial share price of $8.00. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -7.08% in last session and finished the day at $6.69. Traded volume was … Continue reading Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)

Jayne Crisman06/1906/19

Stock Alert: Qihoo 360 Technology (NYSE:QIHU), Aldeyra Therapeutics Inc (NASDAQ:ALDX), Broadway Financial (NASDAQ:BYFC), Astea International Inc. (NASDAQ:ATEA), Euro Tech Holdings (NASDAQ:CLWT)

Qihoo 360 Technology Co Ltd (NYSE:QIHU) has made some solid progress in the Chinese internet industry. And now it is giving tough competition to its peers such as Baidu. In fact, it has been able to take some of its market share and is now competing with Tencent in the gaming market as well. Qihoo 360 Technology Co Ltd (NYSE:QIHU) stock performance was 1.24% in … Continue reading Stock Alert: Qihoo 360 Technology (NYSE:QIHU), Aldeyra Therapeutics Inc (NASDAQ:ALDX), Broadway Financial (NASDAQ:BYFC), Astea International Inc. (NASDAQ:ATEA), Euro Tech Holdings (NASDAQ:CLWT)

Colin Pettis06/06

FB Nasdaq FB Facebook

Biotech decliners: Aldeyra Therapeutics Inc (NASDAQ:ALDX), Uniqure NV (NASDAQ:QURE), Regulus Therapeutics Inc (NASDAQ:RGLS), Genetic Technologies Limited (ADR) (NASDAQ:GENE)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) Director C. Boyd Clarke purchased 12,500 shares of the stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average price of $8.00 per share, with a total value of $100,000.00. Following the acquisition, the director now directly owns 12,500 shares in the company, valued at approximately $100,000. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -8.31% in … Continue reading Biotech decliners: Aldeyra Therapeutics Inc (NASDAQ:ALDX), Uniqure NV (NASDAQ:QURE), Regulus Therapeutics Inc (NASDAQ:RGLS), Genetic Technologies Limited (ADR) (NASDAQ:GENE)

Colin Pettis05/22